Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

Tourmaline Bio is well-funded, with cash runway into 2H 2027, minimizing near-term dilution risk for investors. Click here to ...

The global Burn Care Market is projected to be valued at USD 2.79 billion in 2024 and reach US$ 4.23 billion by 2030, growing ...

Given this risk, we thought we'd take a look at whether MDJM (NASDAQ:UOKA) shareholders should be worried about its cash burn ...

With an expanded product portfolio, Avita Medical is on a concerted US push to win market share and become profitable by the end of the year ...

Australian researchers have developed an innovative technique to 3D print skin to assist in the healing process of patients ...

Shares of biotechnology company Prime Medicine, Inc. (PRME) fell 18% on Monday afternoon after the company announced a ...

But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt. Given this risk, we thought we'd take a look at whether XBiotech (NASDAQ:XBIT) shareholders ...